These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 3936605

  • 1. [Efficacy of the vaccination of C57BL/6 mice against infection with different species of Leishmania].
    Monjour L, Ogunkolade W, Pointet P, Vouldoukis I.
    C R Acad Sci III; 1985; 301(18):803-6. PubMed ID: 3936605
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [An immunologic method of producing antigens for the treatment and prevention of leishmaniasis].
    Vouldoukis I, Monjour L.
    C R Acad Sci III; 1989; 308(5):129-34. PubMed ID: 2493318
    [Abstract] [Full Text] [Related]

  • 6. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
    Lemesre JL, Holzmuller P, Gonçalves RB, Bourdoiseau G, Hugnet C, Cavaleyra M, Papierok G.
    Vaccine; 2007 May 22; 25(21):4223-34. PubMed ID: 17395339
    [Abstract] [Full Text] [Related]

  • 7. Prophylactic immunization against experimental leishmaniasis. IV. Subcutaneous immunization prevents the induction of protective immunity against fatal Leishmania major infection.
    Liew FY, Hale C, Howard JG.
    J Immunol; 1985 Sep 22; 135(3):2095-101. PubMed ID: 4020140
    [Abstract] [Full Text] [Related]

  • 8. Vaccination with a plasmid DNA cocktail encoding the nucleosomal histones of Leishmania confers protection against murine cutaneous leishmaniosis.
    Iborra S, Soto M, Carrión J, Alonso C, Requena JM.
    Vaccine; 2004 Sep 28; 22(29-30):3865-76. PubMed ID: 15364433
    [Abstract] [Full Text] [Related]

  • 9. DNA based vaccination with a cocktail of plasmids encoding immunodominant Leishmania (Leishmania) major antigens confers full protection in BALB/c mice.
    Ahmed SB, Touihri L, Chtourou Y, Dellagi K, Bahloul C.
    Vaccine; 2009 Jan 01; 27(1):99-106. PubMed ID: 18951941
    [Abstract] [Full Text] [Related]

  • 10. Protection against Leishmania major in BALB/c mice by adoptive transfer of a T cell clone recognizing a low molecular weight antigen released by promastigotes.
    Scott P, Caspar P, Sher A.
    J Immunol; 1990 Feb 01; 144(3):1075-9. PubMed ID: 2295814
    [Abstract] [Full Text] [Related]

  • 11. Cross-protection against Leishmania donovani but not L. Braziliensis caused by vaccination with L. Major soluble promastigote exogenous antigens in BALB/c mice.
    Tonui WK, Titus RG.
    Am J Trop Med Hyg; 2007 Mar 01; 76(3):579-84. PubMed ID: 17360887
    [Abstract] [Full Text] [Related]

  • 12. Presentation of the protective parasite antigen LACK by Leishmania-infected macrophages.
    Prina E, Lang T, Glaichenhaus N, Antoine JC.
    J Immunol; 1996 Jun 01; 156(11):4318-27. PubMed ID: 8666803
    [Abstract] [Full Text] [Related]

  • 13. Sub-clinical infection as an effective protocol for obtaining anti-Leishmania chagasi amastigote antibodies of different animal species.
    Fróes AM, dos Santos CV, Penha-Filho ML, Teixeira MC, Correa Silva TM, Oliveira GG, dos Santos WL, Pontes-de-Carvalho LC, Alcântara-Neves NM.
    Vet Immunol Immunopathol; 2004 Jun 01; 99(3-4):135-41. PubMed ID: 15135980
    [Abstract] [Full Text] [Related]

  • 14. Vaccination with plasmid DNA encoding KMPII, TRYP, LACK and GP63 does not protect dogs against Leishmania infantum experimental challenge.
    Rodríguez-Cortés A, Ojeda A, López-Fuertes L, Timón M, Altet L, Solano-Gallego L, Sánchez-Robert E, Francino O, Alberola J.
    Vaccine; 2007 Nov 14; 25(46):7962-71. PubMed ID: 17942199
    [Abstract] [Full Text] [Related]

  • 15. Cysteine proteinase type III is protective against Leishmania infantum infection in BALB/c mice and highly antigenic in visceral leishmaniasis individuals.
    Khoshgoo N, Zahedifard F, Azizi H, Taslimi Y, Alonso MJ, Rafati S.
    Vaccine; 2008 Oct 29; 26(46):5822-9. PubMed ID: 18804512
    [Abstract] [Full Text] [Related]

  • 16. Leishmania major heat shock protein 70 (HSP70) is not protective in murine models of cutaneous leishmaniasis and stimulates strong humoral responses in cutaneous and visceral leishmaniasis patients.
    Rafati S, Gholami E, Hassani N, Ghaemimanesh F, Taslimi Y, Taheri T, Soong L.
    Vaccine; 2007 May 22; 25(21):4159-69. PubMed ID: 17395340
    [Abstract] [Full Text] [Related]

  • 17. Production and characterization of species-specific monoclonal antibodies against Leishmania donovani for immunodiagnosis.
    Jaffe CL, Bennett E, Grimaldi G, McMahon-Pratt D.
    J Immunol; 1984 Jul 22; 133(1):440-7. PubMed ID: 6373932
    [Abstract] [Full Text] [Related]

  • 18. Subspecies- and species-specific antigens of Leishmania mexicana characterized by monoclonal antibodies.
    Pratt DM, Bennett E, Grimaldi G, Jaffe CL.
    J Immunol; 1985 Mar 22; 134(3):1935-40. PubMed ID: 2578524
    [Abstract] [Full Text] [Related]

  • 19. Infections in immunocompetent and immune-deficient mice with promastigotes of a North American isolate of Leishmania infantum.
    Rosypal AC, Zajac AM, Troy GC, Lindsay DS.
    Vet Parasitol; 2005 Jun 10; 130(1-2):19-27. PubMed ID: 15893066
    [Abstract] [Full Text] [Related]

  • 20. Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis.
    Melby PC, Yang J, Zhao W, Perez LE, Cheng J.
    Infect Immun; 2001 Aug 10; 69(8):4719-25. PubMed ID: 11447143
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.